Diabetes and Obesity
Clinical Academic Group
Sydney Health Partners and the University of Sydney are globally recognized leaders for delivering health outcomes for people with diabetes and obesity, across the life-course, through enabling high quality multidisciplinary research, fostering collaborations, increasing the capacity and capabilities of clinician researchers, and improving competitiveness and impact in research translation.
Obesity/overweight affect >80% of those with type 2 diabetes and ~50% of adults with type 1 diabetes. Obesity is the main modifiable risk factor for the progression to type 2 diabetes and is most prevalent in youth onset type 2 diabetes. In developed nations, adverse social determinants of health factors are overrepresented in both diabetes and obesity.
Objectives
The overall purpose of Diabetes and Obesity CAG is to foster and accelerate the targeted translation of ground-breaking research into practice, to better the outcome of patients and communities affected by diabetes and obesity and across the lifespan.
Our working groups and activities will cover consumer priorities with lived experience, mentorship, evidence reviews of research gaps, equity differences in outcomes, professional liaison and specific research studies.
Leadership Team
Our Leadership Group includes internationally recognised academics and clinicians with multidisciplinary expertise in all diabetes and obesity across all ages, from across SLHD, WSLHD, NSLHD, SCHN.
Chairs: Professor Stephen Twigg & Professor Louise Baur
|
|
|
Get Involved
Want to learn more?
Sign up to the Diabetes and Obesity CAG mailing list here.
For all other enquiries, please contact:
stephanie.noonan@sydney.edu.au